GQG Partners
SYNH

GQG Partners’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

GQG Partners’s Portfolio SYNH Stock Details SYNH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-1,247,091
Closed -$128M – 94
2021
Q4 		$128M Buy
1,247,091
+191,182
+18% +$18.4M 0.32% 45
2021
Q3 		$92.4M Sell
1,055,909
-41,910
-4% -$3.79M 0.25% 40
2021
Q2 		$98.2M Buy
1,097,819
+176,935
+19% +$14.9M 0.29% 37
2021
Q1 		$69.8M Buy
+920,884
New +$69.4M 0.26% 47

Other funds holding SYNH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CB
Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

GQG Partners's SYNH Position: Q1 2022 in Review

GQG Partners sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q1 2022, closing a stake of 1,247,091 shares — an estimated $128M sold.

GQG Partners first reported a position in SYNH in Q1 2021 and held it in 4 quarters. The position peaked at $128M in Q4 2021. 366 funds tracked by Wall St. Rank hold SYNH as of Q1 2022.

  • GQG Partners reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q1 2022 after selling out during the quarter.
  • GQG Partners sold 1,247,091 Syneos Health, Inc. Class A Common Stock shares in Q1 2022, an estimated $128M.
  • GQG Partners first reported a position in Syneos Health, Inc. Class A Common Stock in Q1 2021 and held it in 4 quarters.
  • GQG Partners's Syneos Health, Inc. Class A Common Stock position peaked at $128M in Q4 2021.
  • 366 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q1 2022.

Based on GQG Partners's 13F filing for Q1 2022, filed 13 May 2022.